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Question
Treatment of difficult asthma with oral corticosteroids
(OCS) may suppress hypothalamic-pituitary-adrenal
axis. In this study we checked if high doses of cicleso-
nide instead of OCS may restore the adrenal function
without loss of the disease control.
Methods
In five asthmatics with poor control of the disease despite
treatment with systemic corticosteroids OC were replaced
with high doses of ciclesonide (1600-2400 µg/day). The
pulmonary function tests (PFTs), asthma control test and
the morning levels of cortisol and ACTH were measured
at baseline and in 28 and 56 day of treatment.
Results
All patients improved in asthma control scores from mean
value 9,4 to, 19,8 in 70 days. In four subjects FEV1
improved significantly with mean increase of up to 585 ml
in 70 days ACTH levels were normalized in 3 patients
after 28 days of observation and in all patients after
56 days. Cortisol level was normalized in 3 patients after
28 days and in next two subjects after 56 days.
Conclusions
In patients with difficult to treat asthma switching from
the prednisone to high doses of ciclesonide may normalize
hypothalamic pituitary adrenal axis function and improves
the disease control and PFTs.
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